Drug Type Small molecule drug |
Synonyms Benfotiamine/Ursodeoxycholic Acid/Calcium Pantothenate, Vita Active, 비타액티브 |
Target |
Action antagonists |
Mechanism FXR antagonists(Bile acid receptor FXR antagonists), Vitamin B1 supplements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (03 Sep 2026), |
Regulation- |
Molecular FormulaC19H23N4O6PS |
InChIKeyBTNNPSLJPBRMLZ-UHFFFAOYSA-N |
CAS Registry22457-89-2 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00734 | - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Arthralgia | South Korea | 03 Sep 2026 | |
| Beriberi | South Korea | 03 Sep 2026 | |
| Myalgia | South Korea | 03 Sep 2026 | |
| Neuralgia | South Korea | 03 Sep 2026 | |
| Thiamine Deficiency | South Korea | 03 Sep 2026 |





